Cargando…

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Detalles Bibliográficos
Autores principales:	Ando, Kiyohiro, Sanda, Takaomi, Suenaga, Yusuke, Liu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931025/ https://www.ncbi.nlm.nih.gov/pubmed/35311141 http://dx.doi.org/10.3389/fonc.2022.861963

Ejemplares similares

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors
por: Suenaga, Yusuke, et al.
Publicado: (2021)

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma
por: Ando, Kiyohiro, et al.
Publicado: (2020)

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis
por: Ando, Kiyohiro, et al.
Publicado: (2021)

Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
por: Ando, Kiyohiro, et al.
Publicado: (2021)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN
por: Ando, Kiyohiro, et al.
Publicado: (2023)

Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
por: Lindsey, Stephan, et al.
Publicado: (2014)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Editorial: Cell and Developmental Signalling in Neuroblastoma
por: Pulido, Rafael, et al.
Publicado: (2023)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Porf-2 Inhibits Tumor Cell Migration Through the MMP-2/9 Signaling Pathway in Neuroblastoma and Glioma
por: Li, Xue-Yuan, et al.
Publicado: (2020)

Editorial: Insight in cancer genetics: 2022
por: Naro, Chiara, et al.
Publicado: (2022)

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling
por: Paggetti, Jérôme, et al.
Publicado: (2021)

Editorial: New Insights Into the Landscape of Rare Tumors: Translational and Clinical Research Perspective
por: De Vita, Alessandro, et al.
Publicado: (2020)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic
por: Morales La Madrid, Andres, et al.
Publicado: (2015)

Editorial: Insights in thoracic oncology: 2021/2022
por: Parikh, Kaushal, et al.
Publicado: (2022)

Editorial: Insights in head and neck cancer: 2021
por: Lybaert, Willem, et al.
Publicado: (2023)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

Genetic Profile and Clinical Implications of Hepatoblastoma and Neuroblastoma Coexistence in a Child
por: Skoczen, Szymon, et al.
Publicado: (2019)

MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)

Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

Editorial: CRISPR advancement in cancer research and future perspectives
por: Biagioni, Alessio, et al.
Publicado: (2023)

Editorial: Data Based Radiation Oncology—Design of Clinical Trials
por: Kessel, Kerstin Anne, et al.
Publicado: (2018)

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials
por: He, Xing-Xing, et al.
Publicado: (2022)

Future vision for the quality assurance of oncology clinical trials
por: FitzGerald, Thomas J., et al.
Publicado: (2013)

Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021
por: Sulman, Erik P., et al.
Publicado: (2023)

Editorial: Oncolytic Viruses—Genetically Engineering the Future of Cancer Therapy
por: Gesundheit, Benjamin, et al.
Publicado: (2017)

Editorial: Future Perspectives of Sentinel Node Mapping in Gynecological Oncology
por: Santoro, Angela, et al.
Publicado: (2022)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
por: Herling, Marco, et al.
Publicado: (2022)

Editorial: Surgical oncology in the elderly: the state of the art and future challenges
por: Sperti, Cosimo, et al.
Publicado: (2023)

GAPDH in neuroblastoma: Functions in metabolism and survival
por: Cornett, Kevin, et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
por: Cai, Yuanxia, et al.
Publicado: (2020)

Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis
por: He, Bin, et al.
Publicado: (2021)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Editorial: Crosstalk of Mitochondria With Brain Insulin and Leptin Signaling
por: Kleinridders, André, et al.
Publicado: (2018)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iek92gdarma37t5fcvhkfukvte